KEY POINTS
  • The coronavirus shot developed by AstraZeneca and the University of Oxford will be Thailand's "principal vaccine," said Anutin Charnvirakul, Thai deputy prime minister and public health minister.
  • More than 150,000 people have been inoculated with the AstraZeneca vaccine and the percentage of people who developed side effects "is considered very low," said Anutin.
  • Renewed safety concerns around the AstraZeneca-Oxford shot led countries including Germany and Netherlands to halt the use of the vaccine for people under 60.

In this article

The coronavirus shot developed by AstraZeneca and the University of Oxford will be Thailand's "principal vaccine" as the country seeks to revive its crucial tourism sector, the Thai public health minister told CNBC on Monday.  

Renewed safety concerns around the AstraZeneca-Oxford shot led countries including Germany and the Netherlands to halt the use of the vaccine for people under 60.

In this article